DCN and prostate cancer: Ma et al. concluded a novel lncRNA LSAMP-AS1 is involved in the prostate cancer process via targeting miR-183-5p/DCN axis, and they reported that LSAMP-AS1 binds to microRNA-183-5p to suppress the progression of prostate cancer by up-regulating the tumor-suppressor DCN (Ma et al. 2020).